2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology...
1、SGLT2i可减少射血分数轻度降低的心衰(heart failure with mildly reduced ejection fraction,HFmrEF)及射血分数保留的心衰(heart failure with preserved ejection fraction,HFpEF)患者心衰住院或心血管死亡风险。 SGLT2i在LVEF > 40%的症状性心衰患者中进行的...